What if we could reduce the size of a phase III study from 400 to 80 subjects and make it twice as short? Thanks to model-informed clinical trial design, it’s possible!
Watch this inspiring story based on real-world case study data and learn about Simulx® at the same time. In an hour, we will take you from the modeling of phase II studies in Monolix® to the estimation of a phase III study power in Simulx® to finally optimizing sample size and study duration.
